In the fight against these diseases, at IRB Barcelona, they are committed to interdisciplinary research through new projects aimed at better understanding rare diseases and developing new therapies an...
Read moreApproximately 80% of RRDs are genetic in origin, while the remaining 20% are the result of infectious, immunological, degenerative or proliferative diseases. The most important problem faced by patien...
Read moreEndowed with 1.25 million euros, the project is coordinated by IDIBAPS’ Clinical Addictions Research Group (GRAC-GRE), which is led by Hugo López-Pelayo, a researcher and medical specialist at Hosp...
Read moreIniciará su actividad a finales de 2025 y se convertirá, junto al Hospital Sant Joan de Déu Barcelona, en uno de los mayores campus del mundo dedicados a las enfermedades raras.
Read moreThe independent data monitoring committee (IDMC) has recommended continuation of CLINGLIO without modification after its assessment of LAM561 interim efficacy in newly diagnosed Glioblastoma. This fol...
Read moreA study led by IBEC and ISGlobal has demonstrated the antileishmanial potential of an antimalarial compound. Initially designed for malaria, this drug shows high efficacy against leishmaniasis, repres...
Read moreLas dos instituciones han firmado un convenio centrado en tres proyectos científicos sobre estrategias combinadas de inmunoterapia, moléculas para estimular el sistema inmune y terapias CAR-T
Read moreCIRCE Scientific, a leading innovator in the cosmetic and personal care industry, was awarded twice at the 8th Beauty Innovation Days. The company has been honored with two of the six prestigious awar...
Read moreHan conseguido obtener la estructura tridimensional y el mecanismo de acción de la mucinasa HC7, la cual define una nueva familia de mucinasas completamente distinta de las conocidas actualmente, y a...
Read moreEs una metodología extrapolable a otros grupos animales y permite comprender la respuesta de las especies a cambios ambientales
Read moreParticipan en la iniciativa europea ‘Acción Conjunta para la prevención del cáncer y otras enfermedades no transmisibles’ para promover hábitos de vida saludables, especialmente en colectivos ...
Read moreEl grupo ‘Bases Moleculares de los Sistemas Biológicos’ de la Universidad de Málaga (SIBIUMA) forma parte del proyecto internacional ‘EURAS’, que avanza en el estudio de las RASopatías, uno...
Read more